The first German lockdown (March/April 2020) significantly decreased the number of outpatient CT/MRI examinations, although the reduction in the total number of CT/MRI scans was less pronounced. The second German lockdown (January-May 2021) yielded outpatient CT scan results below anticipated levels, while outpatient MRI scan figures exceeded predicted counts in some instances. The cumulative CT and MRI figures, however, remained confined to the predicted range. Compared to CT examinations, lockdowns produced a more substantial decrease in the number of oncological MRI examinations. Despite the lockdowns, the number of therapeutic interventional oncology procedures held steady, showing no substantial reduction.
Interventional oncology procedures remained relatively stable in number during lockdown periods, possibly as a result of a redirection of resource allocation from the more resource-intensive surgical procedures to the less intensive interventional oncology procedures. In the first lockdown, diagnostic imaging procedures decreased in number, contrasting with a less detrimental effect observed during the second lockdown. The oncological MRI examination numbers experienced the most marked and negative consequence. In order to forestall unfavorable results, a system of adaptable patient management protocols must be put in place for and refined during future pandemic occurrences.
Therapeutic interventional oncology procedures were not significantly affected by the COVID-19 lockdowns. A substantial decline in oncological MRI scans was observed during the two lockdown phases.
The following authors: Nebelung H, Radosa CG, Schon F, et al. An investigation into the effect of the COVID-19 pandemic on interventional oncology procedures and diagnostic CT/MRI examinations at a German university hospital. Volume 195 of Fortschritte in der Röntgenstrahlentherapie, 2023, delves into radiology progress on pages 707-712.
The research group including Nebelung H, Radosa C.G., and Schon F, and others. Therapeutic interventional oncology procedures and diagnostic CT/MRI examinations: The COVID-19 pandemic's impact at a German university hospital. Volume 195 of Fortschr Rontgenstr, 2023, encompasses articles from page 707 up to and including page 712.
To determine the radiation burden and diagnostic value of bilateral inferior petrosal sinus sampling in characterizing pituitary versus ectopic adrenocorticotropin-dependent Cushing's syndrome.
The procedural data associated with bilateral inferior petrosal sinus procedures were examined from a retrospective perspective. A comprehensive evaluation of the patients, encompassing clinical and demographic details, radiation exposure during procedures, complication rates, laboratory findings, patient progress, and the calculation of diagnostic test performance, was performed.
Forty-six patients exhibiting adrenocorticotropin-dependent Cushing's syndrome were subjected to a comprehensive evaluation. The bilateral inferior petrosal sinus sampling procedure proved successful in 97.8% of all instances. The middle 50% of fluoroscopy procedure times fell within 78 minutes. Returning a list of sentences, each with a unique structure, is the function of this JSON schema. A median dose area product, calculated from procedural data, was found to be 119 Gy*cm.
Diverse outcomes arise across the 21 to 737 Gy*cm spectrum.
The radiation doses associated with digital subtraction angiography series for visualizing the inferior petrosal sinus were measured at 36 Gy*cm.
The examined dose range, extending from 10 to 181 Gy*cm, encompasses a spectrum of responses.
The overall radiation exposure was markedly impacted by fluoroscopy doses, which were further contingent on the patient's physique. The sensitivity, specificity, positive predictive value, and negative predictive value exhibited values of 84%, 100%, 100%, and 72% prior to corticotropin-releasing hormone stimulation, while post-stimulation, these diagnostic metrics increased to 97%, 100%, 100%, and 93%, respectively. Magnetic resonance imaging studies and bilateral inferior petrosal sinus sampling results showed concordance in only 356% of the examined cases. Twenty-two percent of patients experienced periprocedural complications, one of whom suffered vasovagal syncope during the catheterization.
The safe procedure of bilateral inferior petrosal sinus sampling boasts high technical success rates and excellent diagnostic performance. The intricacy of cannulation and the patient's body type dictate the extent of radiation exposure related to the procedure, demonstrating wide variability. In terms of radiation exposure, fluoroscopy held the largest share. bioorganic chemistry It is appropriate to acquire digital subtraction angiography images to validate the precise placement of the catheter.
Bilateral inferior petrosal sinus sampling, coupled with CRH stimulation, offers a highly accurate method for differentiating pituitary from ectopic Cushing's syndrome. The use of fluoroscopy and patient attributes substantially influence the non-negligible radiation exposure.
A. Augustin, M. Detomas, V. Hartung, et al. A German single-center study examined the procedural aspects of bilateral inferior petrosal sinus sampling. Fortchr Rontgenstr 2023, with DOI 101055/a-2083-9942, presents a study.
Augustin A., Detomas M., and Hartung V., et al. A single-center study in Germany examined bilateral inferior petrosal sinus sampling, yielding procedural data. Fortsch Rontgenstr 2023 features an article with a distinctive DOI, 101055/a-2083-9942.
This case report illustrates corneal perforation as a rare and delayed effect of choroidal melanoma, emphasizing the key histopathological features of this unique and complex combined clinical presentation.
With a 6-month history of corneal perforation leading to the absence of light perception in the right eye, a 74-year-old male patient presented himself to our department. Intraocular pressure was assessed as firm upon palpation. In light of the prolonged identification and adverse visual projection, primary enucleation was carried out.
Upon histopathological examination, a choroidal melanoma with both epithelioid and spindle cell components was detected at the posterior pole, confirming positive staining for Melan-A, HMB45, BAP1, and SOX10. The anterior segment exhibited a complete anterior chamber hemorrhage, marked by blood remaining in the trabecular meshwork. Hemosiderin and hemosiderin-containing macrophages and keratocytes displayed diffuse blood staining across the cornea. Inflammatory cells were absent around the 3mm-wide corneal perforation. medical decision The diagnosis of intraocular heterotopic ossification strongly implied a pre-existing, longstanding condition. A normal cancer staging was observed after the surgical procedure.
Corneal perforation, a late and very rare consequence of advanced choroidal melanoma, can arise from the complex interplay of intraocular hemorrhage, elevated intraocular pressure, and the resultant corneal blood staining.
Advanced choroidal melanoma's uncommon and belated effect, corneal perforation, can be linked to the conjunction of intraocular hemorrhage, elevated intraocular pressure, and resulting symptoms such as corneal staining.
A significant challenge to the German healthcare system in providing patient care arises from both the demographic increase in patient numbers and the current shortfall of medical professionals. The digitalization of urology must be proactively and forcefully advanced to maintain high-quality patient care; the benefits of tools such as online appointment scheduling, video consultations, and digital health applications (DiGAs) will be substantial in enhancing treatment effectiveness. Hopefully, the long-awaited introduction of the electronic patient record (ePA) will spur this process, and medical online platforms may become a permanent feature of novel treatment methods emerging from the urgently required structural shift towards a more digitalized medical landscape, including telemedicine based on questionnaires. A transformation urgently required in today's healthcare system is crucial for the positive advancement of digitization in (urological) medicine, and must be championed by service providers alongside policymakers and administrators.
The German Society of Uro-Oncologists (Deutsche Uro-Onkologen e.V., d-uo) manages a national registry for urothelial cancer (UroNat), and another national registry for prostate cancer (ProNAT). Epacadostat IDO inhibitor These registries in Germany analyze office-based urologists', oncologists', and outpatient hospital departments' provision of care standards for urothelial bladder and upper urinary tract cancer, along with prostate cancer. The treatment process for urothelial and prostate cancer patients, including but not confined to guidelines adherence, must be considered carefully. By employing a scientific approach, these registries aim to meticulously document and analyze the treatment of patients with the two most common urological tumors in Germany. They also analyze the implementation of quality assurance programs to enhance outpatient care. Both registries have the potential to access basic patient information from the d-uo VERSUS registry, a non-interventional, prospective, multicenter study launched in 2018, presently encompassing more than 15,000 patients suffering from diverse urological malignancies. To facilitate more extensive analyses of outpatient treatment results in Germany, the UroNAT and ProNAT registries have included additional variables and elements, going beyond the scope of the German Cancer Registry. Registries, by detailing the current outpatient treatment landscape for urothelial and prostate cancer, seek to identify potential enhancements to patient care and incorporate them into standard clinical practice. Only daily routine diagnostics, clinical courses, and procedures are documented within these non-interventional prospective registries.
In the opening months of 2017, the German Uro-Oncology Society (d-uo) conceived a documentation platform designed to facilitate the reporting of oncology cases by d-uo members to the cancer registry, simultaneously transferring data to the d-uo database, thereby eliminating redundant data entry.